Skip to main content
News Icon

News categories: Publication

Special diet against asthma - publication in Immunity

Can a special diet help in certain cases of asthma? A new study at the University of Bonn at least points to this conclusion. According to the study, mice that were switched to a so-called ketogenic diet showed significantly reduced inflammation of the respiratory tract. The results are now published in the renowned journal "Immunity".

Asthma patients react even to low concentrations of some allergens with severe inflammation of the bronchi. This is also accompanied by increased mucus production, which makes breathing even more difficult. A central role here is played by cells of the innate immune system, which were only discovered a few years ago and are called Innate Lymphoid Cells (ILC). They perform an important protective function in the lungs by regenerating damaged mucous membranes. For this purpose they produce inflammatory messengers from the group of cytokines, which stimulate division of the mucosal cells and promote mucus production.

This mechanism is normally very useful: It allows the body to quickly repair damage caused by pathogens or harmful substances. The mucus then transports the pathogens out of the bronchial tubes and protects the respiratory tract against re-infection. "With asthma, however, the inflammatory reaction is much stronger and longer than normal", emphasizes Prof. Dr. Christoph Wilhelm from the Institute for Clinical Chemistry and Clinical Pharmacology, who is a member of the Cluster of Excellence ImmunoSensation at the University of Bonn. The consequences are extreme breathing difficulties, which can even be life-threatening.


Publication

Fotios Karagiannis, Schekufe Kharabi Masouleh, Klaus Wunderling, Jayagopi Surendar, Vanessa Schmitt, Alexander Kazakov, Marcel Michla, Michael Hölzel, Christoph Thiele & Christoph Wilhelm: Lipid-droplet formation drives pathogenic group 2 innate lymphoid cells in airway inflammation; Immunity; DOI: 10.1016/j.immuni.2020.03.003

Related news

The human P2X4 receptor

News categories: Publication

A starting point for the development of new pain and cancer drugs

The human P2X4 receptor plays an important role in chronic pain, inflammation and some types of cancer. Researchers at the University of Bonn and the University Hospital Bonn (UKB) have now discovered a mechanism that can inhibit this receptor. The results were recently published in the scientific journal Nature Communications and open up a pathway for the development of new drugs. A study carried out by the University of Bonn and the University Hospital Bonn throws light on how P2X2 can be inhibited. The results have recently been published in Nature Communications.
View entry
Kato research group

News categories: Publication

Ominous false alarm in the kidney

Bonn researchers have discovered how a small, naturally occurring RNA molecule in the kidney activates a mutated immune receptor, triggering a chain reaction. In cooperation with Nanyang Technological University Singapore and the University Hospital Würzburg, among others, the study provides an explanation for how a point mutation in the immune receptor RIG-I transforms the body's defense system into a self-destructive force and causes severe organ-specific autoimmune diseases. The results have now been published in the journal Science Immunology.
View entry
News_Proebstel

News categories: Publication

Unique immune signatures to distinguish MOGAD from MS

Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is a rare autoimmune condition in which the body’s immune system mistakenly attacks the protective myelin sheath of nerve fibers in the central nervous system. Although MOGAD induces symptoms similar to multiple sclerosis (MS), its underlying biology appears to be fundamentally different. Understanding these distinctions is crucial for developing effective, disease-specific treatments. A new international study now sheds light on these immune differences.
View entry

Back to the news overview